Kinetic characterization of the catalysis of "activated" cyclophosphamide (4-hydroxycyclophosphamide/aldophosphamide) oxidation to carboxyphosphamide by mouse hepatic aldehyde dehydrogenases.

[1]  C. Manthey,et al.  Effect of aldehyde dehydrogenase inhibitors on the ex vivo sensitivity of human multipotent and committed hematopoietic progenitor cells and malignant blood cells to oxazaphosphorines. , 1987, Cancer research.

[2]  F. Kohn,et al.  Aldehyde dehydrogenase activity as the basis for the relative insensitivity of murine pluripotent hematopoietic stem cells to oxazaphosphorines. , 1985, Biochemical pharmacology.

[3]  N. Sládek,et al.  Restoration of sensitivity to oxazaphosphorines by inhibitors of aldehyde dehydrogenase activity in cultured oxazaphosphorine-resistant L1210 and cross-linking agent-resistant P388 cell lines. , 1985, Cancer research.

[4]  J. Hilton.  Role of aldehyde dehydrogenase in cyclophosphamide-resistant L1210 leukemia. , 1984, Cancer research.

[5]  J. Hilton.  Deoxyribonucleic acid crosslinking by 4-hydroperoxycyclophosphamide in cyclophosphamide-sensitive and -resistant L1210 cells. , 1984, Biochemical pharmacology.

[6]  R. Borch,et al.  Base-catalyzed hydrolysis of 4-hydroperoxycyclophosphamide: evidence for iminocyclophosphamide as an intermediate. , 1984, Journal of medicinal chemistry.

[7]  G. Zon,et al.  NMR spectroscopic studies of intermediary metabolites of cyclophosphamide. A comprehensive kinetic analysis of the interconversion of cis- and trans-4-hydroxycyclophosphamide with aldophosphamide and the concomitant partitioning of aldophosphamide between irreversible fragmentation and reversible co , 1984, Journal of medicinal chemistry.

[8]  T. Hoye,et al.  In situ preparation and fate of cis-4-hydroxycyclophosphamide and aldophosphamide: 1H and 31P NMR evidence for equilibration of cis- and trans-4-hydroxycyclophosphamide with aldophosphamide and its hydrate in aqueous solution. , 1984, Journal of medicinal chemistry.

[9]  N. Sládek,et al.  Further studies on the conversion of 4-hydroxyoxazaphosphorines to reactive mustards and acrolein in inorganic buffers. , 1983, Cancer research.

[10]  B. Domeyer,et al.  Inhibition by cyanamide of 4-hydroxycyclophosphamide/aldophosphamide oxidation to carboxyphosphamide. , 1981, Biochemical pharmacology.

[11]  R. Holmes,et al.  Genetics of aldehyde dehydrogenase isozymes in the mouse: evidence for multiple loci and localization of Ahd-2 on chromosome 19. , 1981, Genetics.

[12]  B. Domeyer,et al.  Metabolism of 4-hydroxycyclophosphamide/aldophosphamide in vitro. , 1980, Biochemical pharmacology.

[13]  P. Cox,et al.  The enzymatic basis of the selective action of cyclophosphamide. , 1975, Cancer research.

[14]  T. Koivula,et al.  Different forms of rat liver aldehyde dehydrogenase and their subcellular distribution. , 1975, Biochimica et biophysica acta.

[15]  D. Hill,et al.  Enzymatic metabolism of cyclophosphamide and nicotine and production of a toxic cyclophosphamide metabolite. , 1972, Cancer research.

[16]  G. N. Wilkinson.  Statistical estimations in enzyme kinetics. , 1961, The Biochemical journal.

[17]  E. Algar,et al.  Liver cytosolic aldehyde dehydrogenases from "alcohol-drinking" and "alcohol-avoiding" mouse strains: purification and molecular properties. , 1986, The International journal of biochemistry.

[18]  E. Algar,et al.  Mouse mitochondrial aldehyde dehydrogenase isozymes: purification and molecular properties. , 1985, The International journal of biochemistry.